“Fei Yan No. 1” as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study

“Fei Yan No. 1” as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study

There has been a large global outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), representing a major public health issue. In China, combination therapy, including traditional Chinese medicine (TCM) as a treatment for COVID-19 has...

Full description

Bibliographic Details
Main Authors: Zhongzhu Ai, Shanshan Zhou, Weinan Li, Mengfan Wang, Linqun Wang, Gangming Hu, Ran Tao, Xiaoqin Wang, Yinfeng Shen, Lihan Xie, Yuanming Ba, Hezhen Wu, YanFang Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Pharmacology
Subjects:
Fei Yan NO1
COVID-19
SARS-CoV-2
clinical efficacy
network pharmacology
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.581277/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.581277/full

Similar Items